R&D News: New ingredients ready for beverage formulation
Solazyme receives FDA GRAS No Questions letter
Kyowa Hakko USA Inc., New York, announced that Phoenix-based G3 Labs Inc.’s minoTor ready-to-drink sports supplement will contain its Sustamine L-Alanyl-L-Glutamine ingredient, which contains a blend of vitamins and other amino acids. MinoTor is a non-carbonated, convenient, premium sports drink designed for active consumers, the company says. Sustamine is a dipeptide of glutamine that infuses minoTOR with several substantial benefits such as enhanced recovery, immune system support, and increased metabolic rate, Kyowa Hakko USA says. On top of these benefits, research suggests that Sustamine is absorbed 240 percent more than standard L-glutamine, it adds. MinoTor is free of artificial colors, flavors and preservatives and contains 50 calories in each serving.
San Francisco-based Solazyme recently received an FDA Generally Recognized as Safe (GRAS) No Questions letter for its whole algal protein, a microalgae-based food ingredient. With the letter, Solazyme’s whole algal protein will further pave the way for mainstream adoption of this new source of vegan protein, enabling the creation of new products that meet consumer demand for healthy, sustainable ingredients, the company says. Solazyme’s food brand, AlgaVia Microalgae Food Ingredients, uses microalgae, a nutrient-filled cell to produce its ingredients including AlgaVia Whole Algal Protein and AlgaVia Whole Algal Flour. Both ingredients now have received No Objection letters, making them the first-ever microalgae-based food ingredients of their kind to be GRAS.